Stay updated with breaking news from Nasdaq Blph. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com began coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Free Report) in a report issued on Thursday morning. The firm issued a hold rating on the biotechnology company’s stock. BLPH has been the subject of a number of other reports. Brookline Capital Management downgraded Bellerophon Therapeutics from a buy rating to a hold rating […]
StockNews.com started coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Free Report) in a research note released on Thursday. The firm issued a hold rating on the biotechnology company’s stock. Other analysts also recently issued research reports about the company. HC Wainwright cut their price objective on Bellerophon Therapeutics from $30.00 to $2.00 in a […]
Stock analysts at StockNews.com assumed coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Get Free Report) in a report issued on Thursday. The brokerage set a “hold” rating on the biotechnology company’s stock. BLPH has been the topic of a number of other research reports. Brookline Capital Management lowered Bellerophon Therapeutics from a “buy” rating […]
Bellerophon Therapeutics, Inc. (NASDAQ:BLPH – Get Free Report)’s stock price crossed below its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $4.33 and traded as low as $0.67. Bellerophon Therapeutics shares last traded at $0.69, with a volume of 125,191 shares traded. Wall Street Analyst […]
Bellerophon Therapeutics, Inc. (NASDAQ:BLPH – Get Rating)’s stock price passed below its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $6.53 and traded as low as $0.68. Bellerophon Therapeutics shares last traded at $0.71, with a volume of 297,101 shares. Analysts Set New Price Targets A number […]